TFEB and neurodegenerative disease: Indeed, studies of postmortem tissues from patients and animal models of neurodegenerative diseases have suggested that impaired TFEB signaling, including abnormal TFEB expression, changes in TFEB subcellular localization, and that abnormal expression of TFEB‐targeting ALP genes may contribute to the pathogenesis of neurodegenerative diseases (Figure 4).